Kurosawa Tohru, Itoh Fumi, Nozaki Aiko, Nakano Yoshihisa, Katsuda Shin-ichiro, Osakabe Naomi, Tsubone Hirokazu, Kondo Kazuo, Itakura Hiroshige
Toxicology Laboratory, Pharmaceutical Development Department, Meiji Seika Kaisha Ltd., 760 Morooka-cho, Kohoku-ku, Yokohama 222-8567, Japan.
Atherosclerosis. 2005 Apr;179(2):237-46. doi: 10.1016/j.atherosclerosis.2004.12.003. Epub 2005 Jan 19.
We investigated the properties of cacao liquor polyphenols (CLP), which have an antioxidative effect on low-density lipoprotein (LDL) and an anti-atherosclerotic effect in the spontaneous familial hypercholesterolemic model, the Kurosawa and Kusanagi-hypercholesterolemic (KHC) rabbit. After 6 months of dietary administration of CLP at 1% (w/w) to the KHC rabbits, a higher total cholesterol concentration was observed in the treatment group compared to the control group. However, no other effects were noted in lipid profiles in plasma or lipoproteins. The plasma concentration of thiobarbituric acid reactive substances (TBARS), which is a lipid-peroxidation index, was significantly decreased 1 month after the start of CLP administration compared to that of the control group. The antioxidative effect of CLP on LDL was observed from 2 to 4 months of administration. The area of atherosclerotic lesions in the aorta in the CLP group (32.01+/-1.58%) was significantly smaller than that in the control group (47.05+/-3.29%), and the tissue cholesterol and TBARS concentrations were lower in the CLP group than in the control group. The anti-atherosclerotic effect of CLP was confirmed both rheologically and histopathologically. An in vitro study using KHC rabbit-derived LDL revealed that CLP significantly prolonged the lag time of LDL oxidation that was induced by a lipophilic azo-radical initiator, 2,2'-azobis(4-methoxy)-2,4-dimethylvaleronitrile (V-70), or Cu(2+) from a low concentration of 0.1 microg/mL. The antioxidative effect of CLP was superior to those of the well-known antioxidative substances, vitamin C, vitamin E and probucol. Therefore, CLP suppressed the generation of atherosclerosis, and its antioxidative effect appeared to have an important role in its anti-atherosclerotic activity.
我们研究了可可液块多酚(CLP)的特性,其对低密度脂蛋白(LDL)具有抗氧化作用,并且在自发性家族性高胆固醇血症模型——黑泽和草柳高胆固醇血症(KHC)兔中具有抗动脉粥样硬化作用。在给KHC兔喂食1%(w/w)的CLP 6个月后,与对照组相比,治疗组的总胆固醇浓度更高。然而,在血浆或脂蛋白的脂质谱中未观察到其他影响。硫代巴比妥酸反应性物质(TBARS)的血浆浓度是脂质过氧化指标,与对照组相比,在CLP给药开始1个月后显著降低。在给药2至4个月时观察到CLP对LDL的抗氧化作用。CLP组主动脉中动脉粥样硬化病变的面积(32.01±1.58%)明显小于对照组(47.05±3.29%),并且CLP组的组织胆固醇和TBARS浓度低于对照组。CLP的抗动脉粥样硬化作用在流变学和组织病理学上均得到证实。一项使用KHC兔来源的LDL进行的体外研究表明,CLP显著延长了由亲脂性偶氮自由基引发剂2,2'-偶氮双(4-甲氧基)-2,4-二甲基戊腈(V-70)或低浓度0.1μg/mL的Cu(2+)诱导的LDL氧化的延迟时间。CLP的抗氧化作用优于著名的抗氧化物质维生素C、维生素E和普罗布考。因此,CLP抑制了动脉粥样硬化的发生,其抗氧化作用似乎在其抗动脉粥样硬化活性中起重要作用。